Eiger BioPharmaceuticals EIGR
$ 1.73
-9.21%
Annual report 2023
added 04-08-2024
Country |
USA |
IPO year |
2014 |
Industry |
Biotechnology |
Stock Exchange |
NASDAQ GLOBAL |
CEO |
Mr. David Cory |
Employees in the company |
29 |
Shares |
1.48 M |
Market Cap[1] |
$ 2.55 M |
EBITDA (LTM) |
$ -90.2 M |
P/E (LTM) |
-0.17 |
P/S (LTM) |
- |
EPS (LTM) |
-2.02 |
Other stocks of industry "Biotechnology"
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.